Literature DB >> 10425190

Heat shock cognate protein 70 is a cell fusion-enhancing factor but not an entry factor for human T-cell lymphotropic virus type I.

D Fang1, Y Haraguchi, A Jinno, Y Soda, N Shimizu, H Hoshino.   

Abstract

Heat shock cognate protein 70 (HSC70) has been shown to bind to the peptide corresponding to amino acids 197 to 216 of human T-cell lymphotropic virus type I (HTLV-I) envelope protein, gp46, and an anti-HSC70 monoclonal antibody (mAb) inhibits HTLV-I-induced syncytium formation. These findings suggest that HSC70 is necessary for the entry of HTLV-I into its target cells. Here we showed that HSC70 directly binds to gp46 by co-immunoprecipitation of HSC70 and gp46 from HTLV-I-producing human T-cell lysate. However, transduction of human HSC70 cDNA into BaF3 cells, which were found to be highly resistant to HTLV-I infection, did not support the HTLV-I entry, and HSC70 expressed in NIH3T3 cells, which were found to be almost resistant to syncytium formation upon cocultivation with HTLV-I-producing cells but sensitive to infection with cell-free HTLV-I, enhanced cell fusion induced by HTLV-I-producing cells, but did not enhance the entry of cell-free HTLV-I into these cells. The mAb against HSC70 inhibited syncytium formation in NIH3T3 cells expressing HSC70, but showed little effect on infection of these cells with cell-free HTLV-I. These findings indicate that HSC70 markedly enhances syncytium formation induced by HTLV-I but does not facilitate HTLV-I entry into target cells. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10425190     DOI: 10.1006/bbrc.1999.1028

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Heat shock cognate protein 70 is involved in rotavirus cell entry.

Authors:  Carlos A Guerrero; Daniela Bouyssounade; Selene Zárate; Pavel Isa; Tomás López; Rafaela Espinosa; Pedro Romero; Ernesto Méndez; Susana López; Carlos F Arias
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 2.  Mechanisms of genetic robustness in RNA viruses.

Authors:  Santiago F Elena; Purificación Carrasco; José-Antonio Daròs; Rafael Sanjuán
Journal:  EMBO Rep       Date:  2006-02       Impact factor: 8.807

Review 3.  Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development.

Authors:  Qianya Wan; Dan Song; Huangcan Li; Ming-Liang He
Journal:  Signal Transduct Target Ther       Date:  2020-07-13

Review 4.  The role of mutational robustness in RNA virus evolution.

Authors:  Adam S Lauring; Judith Frydman; Raul Andino
Journal:  Nat Rev Microbiol       Date:  2013-03-25       Impact factor: 60.633

5.  Antibody to heat shock protein 70 (HSP70) inhibits human T-cell lymphoptropic virus type I (HTLV-I) production by transformed rabbit T-cell lines.

Authors:  Hanan Fallouh; Wahib Mahana
Journal:  Toxins (Basel)       Date:  2012-09-26       Impact factor: 4.546

Review 6.  Current concepts regarding the HTLV-1 receptor complex.

Authors:  David Ghez; Yves Lepelletier; Kathryn S Jones; Claudine Pique; Olivier Hermine
Journal:  Retrovirology       Date:  2010-11-29       Impact factor: 4.602

7.  Cellular Factors Involved in HTLV-1 Entry and Pathogenicit.

Authors:  Hiroo Hoshino
Journal:  Front Microbiol       Date:  2012-06-21       Impact factor: 5.640

8.  Heat Shock Enhances the Expression of the Human T Cell Leukemia Virus Type-I (HTLV-I) Trans-Activator (Tax) Antigen in Human HTLV-I Infected Primary and Cultured T Cells.

Authors:  Marie Kunihiro; Hideki Fujii; Takuya Miyagi; Yoshiaki Takahashi; Reiko Tanaka; Takuya Fukushima; Aftab A Ansari; Yuetsu Tanaka
Journal:  Viruses       Date:  2016-07-11       Impact factor: 5.048

Review 9.  Host cell stress response as a predictor of COVID-19 infectivity and disease progression.

Authors:  Celine Caillet; Melissa Louise Stofberg; Victor Muleya; Addmore Shonhai; Tawanda Zininga
Journal:  Front Mol Biosci       Date:  2022-08-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.